HI
Humankind Investments Portfolio holdings
AUM
$410M
This Quarter Return
-1.06%
1 Year Return
+11.36%
3 Year Return
+48.94%
5 Year Return
–
10 Year Return
–
AUM
$395M
AUM Growth
+$395M
(+43%)
Cap. Flow
+$129M
Cap. Flow
% of AUM
32.75%
Top 10 Holdings %
Top 10 Hldgs %
64.17%
Holding
156
New
15
Increased
71
Reduced
60
Closed
4
Top Buys
| 1 |
Invesco QQQ Trust
QQQ
|
$44.3M |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
$34.7M |
| 3 |
iShares Russell 2000 ETF
IWM
|
$12.3M |
| 4 |
Vanguard Total World Stock ETF
VT
|
$11.9M |
| 5 |
SPDR Gold Trust
GLD
|
$9.69M |
Top Sells
| 1 |
Johnson & Johnson
JNJ
|
$1.82M |
| 2 |
Intel
INTC
|
$250K |
| 3 |
Lennar Class B
LEN.B
|
$224K |
| 4 |
CTLT
CATALENT, INC.
CTLT
|
$221K |
| 5 |
DaVita
DVA
|
$204K |
Sector Composition
| 1 | Technology | 12.75% |
| 2 | Healthcare | 12.24% |
| 3 | Consumer Staples | 5.17% |
| 4 | Communication Services | 2.96% |
| 5 | Materials | 2.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Archer Daniels Midland
ADM
$29.7B
| $2.32M | 0.59% |
45,991
+6,074
| +15% | +$307K |
|
27
Corteva
CTVA
$50.2B
| $2.18M | 0.55% |
38,273
+264
| +0.7% | +$15K |
|
28
Colgate-Palmolive
CL
$68.2B
| $2.05M | 0.52% |
22,538
+2,768
| +14% | +$252K |
|
|
29
Intel
INTC
$106B
| $1.95M | 0.49% |
97,164
-12,488
| -11% | -$250K |
|
30
Becton Dickinson
BDX
$54.1B
| $1.81M | 0.46% |
7,990
+685
| +9% | +$155K |
|
31
Walmart
WMT
$779B
| $1.7M | 0.43% |
18,825
-2,013
| -10% | -$182K |
|
32
Abbott
ABT
$229B
| $1.64M | 0.42% |
14,502
-25
| -0.2% | -$2.83K |
|
33
Amgen
AMGN
$154B
| $1.56M | 0.39% |
5,985
+1,009
| +20% | +$263K |
|
34
Stryker
SYK
$149B
| $1.56M | 0.39% |
4,320
-460
| -10% | -$166K |
|
35
Cigna
CI
$80.3B
| $1.46M | 0.37% |
5,294
+571
| +12% | +$158K |
|
36
CF Industries
CF
$14.1B
| $1.45M | 0.37% |
16,948
-539
| -3% | -$46K |
|
37
Bristol-Myers Squibb
BMY
$96.3B
| $1.42M | 0.36% |
25,151
-2,297
| -8% | -$130K |
|
38
Labcorp
LH
$22.8B
| $1.4M | 0.35% |
6,095
+115
| +2% | +$26.4K |
|
39
GE HealthCare
GEHC
$32.7B
| $1.4M | 0.35% |
17,876
+1,350
| +8% | +$106K |
|
40
Thermo Fisher Scientific
TMO
$183B
| $1.37M | 0.35% |
2,626
+477
| +22% | +$248K |
|
41
Verizon
VZ
$184B
| $1.32M | 0.33% |
32,908
+787
| +2% | +$31.5K |
|
42
Ecolab
ECL
$78B
| $1.32M | 0.33% |
5,615
+134
| +2% | +$31.4K |
|
43
HCA Healthcare
HCA
$94.8B
| $1.3M | 0.33% |
4,317
+573
| +15% | +$172K |
|
44
Dell
DELL
$81.9B
| $1.29M | 0.33% |
11,152
-1,454
| -12% | -$168K |
|
45
UnitedHealth
UNH
$280B
| $1.28M | 0.32% |
2,529
+47
| +2% | +$23.8K |
|
46
AT&T
T
$208B
| $1.25M | 0.32% |
54,727
-6,733
| -11% | -$153K |
|
47
Bunge Global
BG
$16.2B
| $1.22M | 0.31% |
15,746
+1,490
| +10% | +$116K |
|
48
Baxter International
BAX
$12.4B
| $1.17M | 0.3% |
40,157
+6,259
| +18% | +$183K |
|
49
Boston Scientific
BSX
$158B
| $1.13M | 0.29% |
12,676
-654
| -5% | -$58.4K |
|
50
Gilead Sciences
GILD
$140B
| $1.13M | 0.29% |
12,257
-1,891
| -13% | -$175K |
|